The Most Important Women’s Health Advice You’ll Ever Hear
Audio Brief
Show transcript
Dr. Thaïs Aliabadi asks whether you would ever board a plane with a 37 percent chance of crashing. On Mel Robbins's show, in an episode that came out on November 12, 2026, Dr. Aliabadi explains why standard medical guidelines fail women. By the end, you will know the exact screenings, risk scores, and preventative steps to demand at every age to stop reproductive cancers, heart disease, and dementia.
How fighting medical dismissal can save your life. The healthcare system routinely minimizes women's pain as stress, anxiety, or poor sleep, which is why Dr. Aliabadi uses an aggressive, proactive protocol and notes that in 25 years of practice, she has never lost a patient who followed all her instructions. If a doctor tells you your symptoms are in your head or your labs are normal, get a second or third opinion.
Why waiting until age 40 for a mammogram is a dangerous myth. Dr. Aliabadi had no family history or genetic mutations, yet a biopsy showing atypical cells pushed her lifetime risk to 37 percent, and the preventative double mastectomy she demanded over her surgeons' objections uncovered invasive Stage 1 cancer. Use the free online Tyrer Cuzick calculator by age 25 to 30, and if your score is 20 percent or higher, demand annual 3D mammograms, ultrasounds, and MRIs starting at age 30.
Knowing yourリスク is only step one, because you also need to see what standard scans miss.
How dense breast tissue hides tumors in plain sight. Because both dense tissue and cancer show up white on standard 2D mammograms, tumors get masked, like a snowball in a blizzard. Even if you are low risk, ask for a baseline 3D mammogram and breast ultrasound at age 35, especially if you have dense breasts.
How hidden genetic markers raise your cancer risk even when standard gene tests are negative. Whole genome sequencing calculates a polygenic risk score by adding up hundreds of tiny genetic markers that individually lack power, like pebbles weighing as much as a boulder, which explained why Dr. Aliabadi was three times more likely to get breast cancer. If cancer runs in your family, get genetic testing at age 25 alongside a baseline hormone panel.
Where ovarian cancer actually starts, and the one minute scan that catches uterine cancer early. Research cited by Dr. Aliabadi and corroborated by Mel Robbins via Breakthrough Cancer shows that 65 to 85 percent of ovarian cancers actually start in the fallopian tubes. Removing the tubes in a 10 to 15 minute outpatient surgery, though it can take longer for some, drastically cuts ovarian cancer risk while leaving the ovaries intact to make hormones and avoid surgical menopause. Request a one minute transvaginal pelvic ultrasound at every annual exam once sexually active, and insist on a 10 second office biopsy if your postmenopausal uterine lining measures 4 millimeters or thicker.
How to make cervical cancer nearly 100 percent preventable. Out of 100 HPV strains, two high risk strains called HPV 16 and 18 are heavily linked to cancer, and testing positive for either one requires a cervical biopsy called a colposcopy even if your Pap smear is normal. Make sure everyone gets the HPV vaccine, approved for ages 9 to 46, and start Pap smears with HPV testing at age 21 or three years after first sexual intercourse.
The simple blood tests and hormone timing that protect your brain and heart after 35. Up to a quarter of women carry one copy of the ApoE4 gene variant that raises Alzheimer's risk, though starting hormone replacement therapy within the first seven years of menopause lowers that risk. Track perimenopause symptoms starting at 35, and order ApoE4 and fasting ApoB blood tests to protect your brain and keep your ApoB below Dr. Aliabadi's target of 60.
Standard medical guidelines and normal routine labs are not enough to protect women from preventable cancers, heart disease, and dementia, so you must proactively demand your own baseline imaging, risk scores, and genetic tests. When it comes to women's health, don't let them dismiss you.
Episode Overview
- Dr. Thaïs Aliabadi tells Mel Robbins which specific medical screenings, risk calculations, and preventive measures women should demand at every age to detect and prevent reproductive cancers, heart disease, and dementia.
- The conversation begins with Dr. Aliabadi's personal breast cancer diagnosis, illustrating how even a physician with no family history or major genetic mutations had to fight medical dismissal to save her own life.
- Dr. Aliabadi breaks down the biology and hidden risk factors of breast, ovarian, uterine, and cervical cancers, explaining why standard national screening guidelines often fail to catch diseases at early, curable stages.
- The episode concludes with a comprehensive, decade-by-decade checklist of blood tests, imaging, and surgical or hormonal interventions for women from their teens through post-menopause.
Key Concepts
- Medical Dismissal and the "Aliabadi Standard of Care": The healthcare system routinely minimizes women's pain, attributing physical symptoms to stress, anxiety, or poor sleep, and relies heavily on normal routine blood work even though a patient can have completely normal labs while harboring breast cancer. Because standard guidelines fail many patients, Dr. Aliabadi practices an aggressive, proactive protocol she calls the "Aliabadi standard of care," noting that in 25 years of practice, she has never lost a patient who followed all of her instructions.
- Lifetime Breast Cancer Risk vs. The Age 40 Myth: An average American woman has a 12.5% lifetime chance of developing breast cancer, and 85% of women diagnosed have no family history of the disease. Waiting until age 40 for a mammogram is misleading for high-risk women. When Dr. Aliabadi had no family history or genetic mutations, her baseline risk was under 10%, but an excisional biopsy showing "atypical cells" in her left breast pushed her calculated lifetime risk to 37%. Despite surgeons calling her paranoid and one telling her the day before surgery that they have really good chemo for breast cancer, she demanded a prophylactic double mastectomy, which uncovered invasive Stage 1 cancer in her right breast. Furthermore, after two radiologists dismissed her post-op concerns, a third opinion and a second double mastectomy 6 weeks later revealed the first surgeon had left 35% of her breast tissue behind.
- Breast Density and Preventative Interventions: About 50% of women have dense breast tissue (more glandular and fibrous tissue, less fat). Dense tissue both increases breast cancer risk and masks tumors on standard 2D mammograms because both dense tissue and cancer appear white, making 3D mammograms and ultrasounds essential. For women with a very high lifetime risk (which Dr. Aliabadi considers 35% or above), preventative options include a prophylactic double mastectomy or taking Tamoxifen (a hormone blocker) for 5 years to reduce breast cancer risk by 50%.
- Genetic Testing vs. Polygenic Risk Scores: Less than 5% to 10% of women who get breast cancer carry one of the 11 (as Dr. Aliabadi notes, "if I'm not mistaken") major gene mutations directly linked to the disease, such as BRCA. However, whole genome sequencing (Dr. Aliabadi used Simplified Genomics to analyze "maybe 6.4 billion" DNA pairs and 2,100 diseases) evaluates a polygenic risk score. This score measures hundreds of tiny genetic markers that individually lack power but accumulate to raise risk as much as a major mutation, which explained why Dr. Aliabadi was 3 times more likely to get breast cancer despite testing negative for major mutations.
- Ovarian and Uterine Cancer Origins: While BRCA mutations, Lynch syndrome, and endometriosis increase ovarian cancer risk, research cited by Dr. Aliabadi (and corroborated by Mel Robbins via the foundation Breakthrough Cancer) shows that 65% to 85% of ovarian cancers actually originate in the fallopian tubes. Consequently, removing the fallopian tubes (a 10-to-15-minute outpatient laparoscopic salpingectomy, though it can take longer for some) drastically reduces ovarian cancer risk while leaving the ovaries intact to produce hormones and avoid surgical menopause. For uterine cancer, monitoring the inner uterine lining (endometrial echo complex) after menopause is vital; if it measures 4 millimeters or thicker on an ultrasound, even without bleeding, an immediate 10-second office biopsy is required to catch cancer at Stage 1.
- HPV and Cervical Cancer Prevention: Almost all cervical cancers are caused by the human papillomavirus (HPV), making the disease nearly 100% preventable through vaccination and screening. Of the 100 HPV strains, about 30 affect the genital area, 15 are high-risk, and two specific strains (HPV 16 and HPV 18) are heavily linked to cervical cancer. Even if a woman's Pap smear is negative, testing positive for HPV 16 or 18 requires a colposcopy to biopsy the cervix.
- Longevity Biomarkers (Perimenopause, ApoE4, and ApoB): The average age of menopause is 51.5 (ranging from 45 to 55), and perimenopause begins 7 to 10 years prior, meaning symptoms like sleep disruption, weight gain, joint pain, and brain fog can start at age 35. Beyond reproductive health, 20% to 25% of women carry one copy of the ApoE4 gene variant (and 2% carry two copies), which elevates Alzheimer's risk; however, recent data shows starting hormone replacement therapy (HRT, such as micronized progesterone and estrogen) within the first 7 years of menopause reduces Alzheimer's risk in ApoE4 carriers. To prevent heart attacks (the number one killer), an ApoB blood test is critical because it measures four plaque-forming particles: LDL, IDL, VLDL, and Lipoprotein(a) [Lp(a)], a genetic particle found in 20% of people that drives early heart attacks even in fit, healthy eaters.
Quotes
- At 2:27 - "Let me tell you, under my care for the past 25 years, I've never lost a patient who did exactly everything I told her to do." - Dr. Aliabadi establishing the efficacy of her proactive, aggressive clinical protocols.
- At 5:03 - "Mel, if I told you you were about to board a plane that had a 37% chance of crashing, would you board that plane with your family?" - Dr. Aliabadi explaining why she insisted on a double mastectomy after an atypical biopsy raised her lifetime risk score, despite her doctors calling her paranoid.
- At 8:42 - "After I woke up, he said, 'I'm so glad you had me do it. They had left 35% of your breast tissue behind.'" - Dr. Aliabadi recounting the aftermath of her second double mastectomy, proving why women must push for second and third opinions when they feel something is wrong.
- At 11:39 - "The age 40 for mammogram is completely misleading. You need to know your own lifetime risk of breast cancer, and based on that number, then we give you directions on when to start your breast imaging." - Dr. Aliabadi explaining why standardized age guidelines fail women who are at elevated risk.
- At 16:45 - "Don't come to my office and tell me, 'I don't have family history of breast cancer, so I'm not going to get breast cancer.' It's not true. 85% of women who get breast cancer don't have a family history of it." - Dr. Aliabadi debunking the most common false reassurance women and doctors rely on.
- At 25:04 - "If there's one other thing I would change in this country and make it mandatory, I would have every single woman on the planet get an annual pelvic ultrasound." - Dr. Aliabadi sharing the one-minute well-woman screening practice that allows her to catch ovarian and uterine cancers at Stage 1 and Stage 2.
- At 26:09 - "Did you know that if you remove someone's fallopian tubes, you can significantly reduce their risk of ovarian cancer? Because they did a study, 65, some people say 85% of ovarian cancers start in the tube." - Dr. Aliabadi explaining how salpingectomy acts as a powerful preventative measure without inducing surgical menopause.
- At 35:09 - "You can have a completely normal lab and have breast cancer. So don't tell me that your labs were normal." - Dr. Aliabadi warning listeners that routine blood panels cannot be used to rule out malignancies or dismiss patient symptoms.
- At 51:52 - "My parting words is when it comes to women's health, don't let them dismiss you. Don't let them tell you it's in your head. Don't let them tell you it's normal. Don't let them tell you your labs are normal so you don't have the condition. If you get dismissed, go get a second opinion. If you still get dismissed, go get a third opinion." - Dr. Aliabadi's final call to action for self-advocacy in a healthcare system that routinely minimizes women's complaints.
Takeaways
- Calculate Your Breast Cancer Risk by Age 25 to 30: Use the free online Tyrer-Cuzick Model calculator (skipping the breast density question if you haven't had a mammogram). If your score is 20% or higher (high risk), demand annual 3D mammograms, breast ultrasounds, and breast MRIs starting at age 30, and coach your doctor to write "high lifetime risk" on the MRI order so insurance covers it; if your risk is 15% to 20% (intermediate), get a baseline mammogram and ultrasound at 35 with an MRI every 3 years; if you have a family history, start imaging 10 years earlier than your relative's diagnosis age.
- Demand Annual Pelvic Ultrasounds and Timely Preventive Surgeries: Request a 1-minute transvaginal pelvic ultrasound at every annual exam once sexually active, and insist on a 10-second office uterine biopsy if your postmenopausal uterine lining measures 4 mm or greater. If you are done having children and have elevated ovarian cancer risk or endometriosis, discuss laparoscopic fallopian tube removal (salpingectomy) while keeping your ovaries until menopause, unless you are BRCA-positive, in which case you must have your ovaries removed by age 40.
- Execute the Early-Adulthood Screening Checklist (Teens to 30s): Screen teenagers for endometriosis and PCOS, ensure everyone gets the HPV vaccine (approved for ages 9 to 46), and begin Pap smears with HPV testing at age 21 or 3 years after first sexual intercourse. Check your baseline egg count with an AMH blood test between ages 18 and 20, consider freezing your eggs between ages 28 and 32 (which costs $10,000 to $35,000 per cycle) if delaying pregnancy, and at age 25, get genetic testing if cancer runs in your family alongside a baseline hormone panel (free and total testosterone, prolactin, DHEA-S, full thyroid panel, and Hemoglobin A1C if overweight).
- Schedule Midlife Baselines and Manage Perimenopause (35 to 40s): Get a baseline 3D mammogram and ultrasound at age 35 (even if low-risk, especially if you have dense breasts), a baseline bone density scan in your 40s (since the greatest bone loss occurs in the first 5 years of menopause), and a baseline colonoscopy at age 45 (or 10 years prior to a relative's diagnosis). Track perimenopause symptoms starting at age 35 and talk to your doctor about starting estrogen and micronized progesterone (HRT) based on symptoms rather than waiting for your periods to stop completely.
- Test for Alzheimer's and Heart Disease Risk at 50+: Order an ApoE4 blood test to check for Alzheimer's genetic risk; if positive, prioritize exercise, 7+ hours of sleep, omega-3s, zero alcohol or smoking, methylated B vitamins to lower high homocysteine levels, and HRT within the first 7 years of menopause. Additionally, order a fasting ApoB blood test (ideally through Cleveland Clinic or Boston Heart labs) to measure plaque-forming particles including Lp(a), aiming to keep your ApoB below Dr. Aliabadi's target of 60 (noting it is "not a magical number") or a longevity cardiologist's target of 40.